Literature DB >> 28937230

Vagal-immune interactions involved in cholinergic anti-inflammatory pathway.

I Zila1, D Mokra, J Kopincova, M Kolomaznik, M Javorka, A Calkovska.   

Abstract

Inflammation and other immune responses are involved in the variety of diseases and disorders. The acute response to endotoxemia includes activation of innate immune mechanisms as well as changes in autonomic nervous activity. The autonomic nervous system and the inflammatory response are intimately linked and sympathetic and vagal nerves are thought to have anti-inflammation functions. The basic functional circuit between vagus nerve and inflammatory response was identified and the neuroimmunomodulation loop was called cholinergic anti-inflammatory pathway. Unique function of vagus nerve in the anti-inflammatory reflex arc was found in many experimental and pre-clinical studies. They brought evidence on the cholinergic signaling interacting with systemic and local inflammation, particularly suppressing immune cells function. Pharmacological/electrical modulation of vagal activity suppressed TNF-alpha and other proinflammatory cytokines production and had beneficial therapeutic effects. Many questions related to mapping, linking and targeting of vagal-immune interactions have been elucidated and brought understanding of its basic physiology and provided the initial support for development of Tracey´s inflammatory reflex. This review summarizes and critically assesses the current knowledge defining cholinergic anti-inflammatory pathway with main focus on studies employing an experimental approach and emphasizes the potential of modulation of vagally-mediated anti-inflammatory pathway in the treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28937230     DOI: 10.33549/physiolres.933671

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  20 in total

1.  Oral NaHCO3 Activates a Splenic Anti-Inflammatory Pathway: Evidence That Cholinergic Signals Are Transmitted via Mesothelial Cells.

Authors:  Sarah C Ray; Babak Baban; Matthew A Tucker; Alec J Seaton; Kyu Chul Chang; Elinor C Mannon; Jingping Sun; Bansari Patel; Katie Wilson; Jacqueline B Musall; Hiram Ocasio; Debra Irsik; Jessica A Filosa; Jennifer C Sullivan; Brendan Marshall; Ryan A Harris; Paul M O'Connor
Journal:  J Immunol       Date:  2018-04-16       Impact factor: 5.422

Review 2.  The Critical Role of the Central Autonomic Nervous System in Fetal-Neonatal Transition.

Authors:  Sarah B Mulkey; Adre Dú Plessis
Journal:  Semin Pediatr Neurol       Date:  2018-06-20       Impact factor: 1.636

3.  Electric vagal nerve stimulation inhibits inflammation and improves early postoperation cognitive dysfunction in aged rats.

Authors:  Jun Xiong; Huijun Wang; Yin Bao; Yuliang Guo; Yongxing Sun
Journal:  BMC Anesthesiol       Date:  2019-11-23       Impact factor: 2.217

Review 4.  Neurotransmitters: emerging targets in cancer.

Authors:  Shu-Heng Jiang; Li-Peng Hu; Xu Wang; Jun Li; Zhi-Gang Zhang
Journal:  Oncogene       Date:  2019-09-16       Impact factor: 9.867

5.  Gut microbiota modulates the inflammatory response and cognitive impairment induced by sleep deprivation.

Authors:  Zhong Wang; Wen-Hao Chen; Su-Xia Li; Zhong-Ming He; Wei-Li Zhu; Yan-Bin Ji; Zhe Wang; Xi-Mei Zhu; Kai Yuan; Yan-Ping Bao; Le Shi; Shi-Qiu Meng; Yan-Xue Xue; Wen Xie; Jie Shi; Wei Yan; Hong Wei; Lin Lu; Ying Han
Journal:  Mol Psychiatry       Date:  2021-05-07       Impact factor: 15.992

6.  Does cardiovascular autonomic dysfunction contribute to fatigue in myasthenia gravis?

Authors:  A Elsais; E Kerty; K Russell; K Toska
Journal:  Physiol Res       Date:  2022-01-19       Impact factor: 1.881

Review 7.  The greater inflammatory pathway-high clinical potential by innovative predictive, preventive, and personalized medical approach.

Authors:  Greg Gibson; Luigi Manni; Christine Nardini; Maria Giovanna Maturo; Marzia Soligo
Journal:  EPMA J       Date:  2019-12-10       Impact factor: 6.543

Review 8.  Cholinergic anti-inflammatory pathway and connective tissue diseases.

Authors:  Khalil Hajiasgharzadeh; Alireza Khabbazi; Ahad Mokhtarzadeh; Amir Baghbanzadeh; Zahra Asadzadeh; Elham Adlravan; Behzad Baradaran
Journal:  Inflammopharmacology       Date:  2021-06-14       Impact factor: 4.473

9.  Cardiac Autonomic Dysfunction in Myasthenia Gravis and Relapsing-Remitting Multiple Sclerosis-A Pilot Study.

Authors:  Łukasz Rzepiński; Monika Zawadka-Kunikowska; Julia L Newton; Paweł Zalewski
Journal:  J Clin Med       Date:  2021-05-18       Impact factor: 4.241

Review 10.  Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection.

Authors:  Júlia Leão Batista Simões; Julia Beatrice de Araújo; Margarete Dulce Bagatini
Journal:  Mol Neurobiol       Date:  2021-07-11       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.